Description
Product details
GLICLAGLAZE TRIO 40/0.3 is a prescription medication used for managing type 2 diabetes. It contains a combination of three active ingredients—Gliclazide IP (40 mg), Metformin Hydrochloride IP (500 mg), and Voglibose IP (0.3 mg)—each targeting different pathways to help control blood sugar levels. Key Benefits: Provides comprehensive blood sugar control for patients with type 2 diabetes. Reduces fasting and post-meal glucose levels. Lowers the risk of complications associated with high blood sugar, such as cardiovascular issues and neuropathy. How Does It Work? Gliclazide enhances insulin secretion from the pancreas. Metformin decreases glucose production in the liver and improves insulin sensitivity. Voglibose slows the breakdown of carbohydrates in the intestines, minimizing sudden spikes in blood sugar levels after meals. Directions for Use: Take this medication as directed by your healthcare provider, typically once or twice daily with meals. Swallow the tablet whole with water. Do not crush or chew the tablet. Regularly monitor your blood sugar levels as advised by your doctor. Side Effects: Common: Nausea, diarrhea, stomach pain, and low blood sugar (hypoglycemia). Less Common: Headaches, dizziness, and mild gastrointestinal discomfort. Rare but Severe: Severe hypoglycemia, lactic acidosis (with metformin), or allergic reactions.
